Inactivated Hepatitis A Vaccine

AIM Action Biopharmaceutical Co., Ltd. is a manufacturer of Inactivated Hepatitis A Vaccine from China, and its products are highly reliable in terms of safety, making them particularly suitable for a wide range of people, including children, the elderly, and those with compromised immune systems.

Thanks to our mature and reliable technology and stable protective effects, our products are trusted by disease control centers and have been included in China's national immunization program vaccine list.

Product Features

The inactivated hepatitis A vaccine produced by AIM Action Biopharmaceutical Co., Ltd. represents one of the most classic and safe approaches in vaccine technology. Through precise cultivation, harvesting, and purification, this product employs rigorous physical or chemical methods to completely inactivate the hepatitis A virus, rendering it incapable of causing disease or replicating.

Simultaneously, it meticulously preserves the antigenic structures that stimulate the human body to produce protective antibodies. This "armor-only, no blades" philosophy ensures absolute biological safety in vaccination.

As a mature technology validated globally over decades, the inactivated vaccine provides a worry-free protection against potential viral reactivation, serving as a solid foundation for building hepatitis A immunity.

What Are the Advantages of Our Vaccine?

1. Safety, No Infection Risk: The key advantage lies in the complete inactivation of viruses, ensuring that the vaccine itself will not cause hepatitis A infection after administration, providing extremely high safety.

2. Technologically mature and proven: Inactivation is a vaccine science classic with stable manufacturing processes, clear quality control parameters, and a long history of safety use across billions of doses worldwide.

3. High stability and ease of storage/transportation: Inactivated vaccines are generally less sensitive to temperature fluctuations. Under strict 2-8℃ cold chain conditions, they maintain superior stability, ensuring full potency throughout the distribution process from AIM's production factories to vaccination sites.

4. Extensive applicability: Inactivated hepatitis A vaccines are not only safe for healthy people, but also for vulnerable groups such as immunocompromised persons, people with chronic diseases, older persons and pregnant women (if they need to be vaccinated).

Inactivated Vaccines vs. Live Attenuated Vaccines: A Core Decision in Technological Approaches

● AIM Action’s HAV is an inactivated vaccine, does not contain live virus, has no risk of secondary transmission, and avoids the risk of atavism of virulence.
● It does not replicate in liver cells and does not lead to abnormal liver function

Application Scenarios

Universal preventive care: Inactivated hepatitis A vaccine is the most popular choice for hepatitis A prevention in national immunization programmes or out-of-pocket vaccination, and is suitable for all susceptible persons over 1 year of age.

People with special health conditions: Safe protection against hepatitis A for people with chronic liver disease, people living with HIV, people who are receiving immunosuppressive therapy and others with compromised immune function.

Public health emergencies: In the event of an outbreak of hepatitis A, inactivated vaccines can be used quickly and safely for emergency vaccination of key populations, rapidly establishing an immune barrier.